Trial Profile
Chinese PLA Generation Hospital
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Therapeutic Use
- 11 Apr 2017 Status changed from not yet recruiting to recruiting.
- 30 Mar 2017 New trial record